aldosterone antagonist
Showing 1 - 25 of 2,126
AFib Trial in Atlanta (Spironolactone, No Spironolactone)
Recruiting
- AFib
- Spironolactone
- No Spironolactone
-
Atlanta, GeorgiaPiedmont Heart Institute
Feb 3, 2022
Heart Failure With Preserved Ejection Fraction Trial in Porto (Dapagliflozin, Spironolactone, Spironolactone + Dapagliflozin)
Recruiting
- Heart Failure With Preserved Ejection Fraction
- Dapagliflozin
- +2 more
-
Porto, Portugal
- +1 more
Jan 12, 2023
Idiopathic Membranous Nephropathy Trial in Paris (symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II,
Completed
- Idiopathic Membranous Nephropathy
- symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)
- experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
-
Paris, FranceDepartment of Nephrology , Tenon hospital - APHP
Oct 18, 2021
Heart Failure, Hyperkalemia Trial in Gothenburg (Sodium zirconium cyclosilicate, Placebo)
Recruiting
- Heart Failure
- Hyperkalemia
- Sodium zirconium cyclosilicate
- Placebo
-
Gothenburg, SwedenSahlgrenska University Hospital-Ostra Hospital
Sep 20, 2021
Glucose Metabolism in Aldosterone-Producing Adenomas
Completed
- Primary Aldosteronism
- Adrenalectomy
- mineralocorticoid receptor antagonist
-
Nashville, TennesseeVanderbilt University Medical Center
Apr 28, 2021
Salt Taste Threshold in Patients Being Investigated for Primary
Unknown status
- Hyperaldosteronism; Primary
- +3 more
- adrenalectomy
- Aldosterone Antagonist
-
London, United KingdomImperial College Healthcare NHS Trust
Sep 15, 2020
Renin Angiotensin Aldosterone System Genetic Polymorphism on
Recruiting
- Myocardial Infarction
-
Cairo, EgyptAin Shams University
May 16, 2023
End Stage Renal Failure on Dialysis Trial in Belgium, France, Monaco (Spironolactone, Placebo)
Active, not recruiting
- End Stage Renal Failure on Dialysis
- Spironolactone
- Placebo
-
Bruxelles, Belgium
- +68 more
Oct 27, 2020
Metabolic Syndrome, Hypertension, Overweight and Obesity Trial in Boston (Eplerenone, Chlorthalidone with potassium chloride)
Recruiting
- Metabolic Syndrome
- +2 more
- Eplerenone
- Chlorthalidone with potassium chloride
-
Boston, MassachusettsBrigham and Women's Hospital
Feb 28, 2022
High-dose Aldosterone Antagonist for Acute Decompensated Heart
Completed
- Acute Decompensated Heart Failure
- Spironolactone and patiromer
-
San Antonio, TexasShweta Bansal
Apr 30, 2019
Chronic Right-Sided Heart Failure, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Primary, 2 Trial in Ottawa (drug,
Recruiting
- Chronic Right-Sided Heart Failure
- +5 more
- Spironolactone
- +3 more
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Nov 19, 2021
Hypertension, Hyperaldosteronaemia Trial (Spironolactone, Finerenone, Blank control)
Not yet recruiting
- Hypertension
- Hyperaldosteronaemia
- Spironolactone
- +2 more
- (no location specified)
Jan 15, 2023
Primary Aldosteronism in Blacks
Recruiting
- Adrenal Gland Neoplasm
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 11, 2022
Hypertension, Mineralocorticoid Excess Trial in Boston (Eplerenone, Amlodipine)
Recruiting
- Hypertension
- Mineralocorticoid Excess
-
Boston, MassachusettsBrigham and Women's
Jul 20, 2022
Hypertension, Genetics Hypertension Trial in Boston (Eplerenone vs Amlodipine)
Recruiting
- Hypertension
- Genetics Hypertension
- Eplerenone vs Amlodipine
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 11, 2021
Hypertension, Left Ventricular Hypertrophy Trial (Eplerenone, Chlorthalidone, Potassium)
Not yet recruiting
- Hypertension
- Left Ventricular Hypertrophy
- Eplerenone
- +2 more
- (no location specified)
Oct 26, 2022
Myocardial Fibrosis, Hypertrophic Cardiomyopathy Trial in Boston (Spironolactone, Placebo)
Completed
- Myocardial Fibrosis
- Hypertrophic Cardiomyopathy
- Spironolactone
- Placebo
-
Boston, MassachusettsTufts Medical Center
Mar 31, 2021
Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)
Enrolling by invitation
- Chronic Kidney Diseases
- Zibotentan
- +3 more
-
Aurora, Colorado
- +5 more
Oct 18, 2022
Water and Electrolytes Content in HYpertension (WHYSKI) in SKIn
Recruiting
- Hyperaldosteronism
- +7 more
- Skin Biopsy
- Video-laparoscopic adrenalectomy
-
Padova, ItalyAzienda Ospedale Università di Padova
Oct 23, 2023
Bioequivalence, Healthy Subjects Trial in Amman (Efez 50 mg eplerenone film-coated tablets, INSPRA® 50 mg eplerenone film-coated
Completed
- Bioequivalence
- Healthy Subjects
- Efez 50 mg eplerenone film-coated tablets
- INSPRA® 50 mg eplerenone film-coated tablets
-
Amman, JordanACDIMA Center for Bioequivalence and Pharmaceutical Studies
Dec 15, 2022
Heart Failure Trial in Gallup (EHR-based GDMT Optimization)
Not yet recruiting
- Heart Failure
- EHR-based GDMT Optimization
-
Gallup, New MexicoGallup Indian Medical Center
Mar 17, 2023
Primary Aldosteronism, Resistant Hypertension, Secondary Hypertension Trial in Boston (Best Practice Advisory Computerized
Not yet recruiting
- Primary Aldosteronism
- +5 more
- Best Practice Advisory Computerized Alert
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 22, 2023
Adherence to Drug Therapy in Patients With HFrEF Trial in Quedlinburg
Active, not recruiting
- Adherence to Drug Therapy in Patients With HFrEF
-
Quedlinburg, Saxony-Anhalt, GermanyParacelsus Harz Clinic Bad Suderode
Sep 15, 2022
Heart Failure Trial in United States (Biobeat Wrist Watch, Standard of Care)
Terminated
- Heart Failure
- Biobeat Wrist Watch
- Standard of Care
-
New Haven, Connecticut
- +7 more
Dec 2, 2021